Similar Search Results

Shifting the Risk in Pricing and Reimbursement Schemes? A Model of Risk-Sharing Agreements for Innovative Drugs

Capri, Stefano; Levaggi, Rosella - 2011

effectiveness of the drug (i.e. the efficacy resulted in the real medical practice). We assume that the probability of being listed … price is set according to the declared efficacy of the new drug, but if ex post the effectiveness falls short of what … (approved and reimbursed) depends on the relative performance of the new drug in terms of effectiveness and budget required. The …

Persistent link: https://www.econbiz.de/10014181847

Drug Pricing and Risk Sharing Agreements

Capri, Stefano; Levaggi, Rosella - 2008

note we present a specific risk sharing agreement on effectiveness and show how such mechanism is going to affect the … market in the long run. In particular, we will show how the regulator may create a trade off between expected efficacy and …

Persistent link: https://www.econbiz.de/10014217551

International Price Regulations in the Pharmaceutical Sector : A Common Model to Sharing the Benefits

Levaggi, Rosella; Capri, Stefano - 2005

In this article we analyse the market for drugs in health care markets where third payers (an insurance company or a government agency) bear the cost and we suggest a common and transparent methodology to set the price for new drugs as well as active principles for which an alternative already...

Persistent link: https://www.econbiz.de/10014028693

Risk-sharing agreements in pharmaceutical markets

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo; … - In: Estudios de economía aplicada : revista promovida por … 31 (2013) 2, pp. 359-378

Persistent link: https://www.econbiz.de/10010207164

Patent Pools and Diagnostic Testing

Van Overwalle, Geertrui - 2015

There is increasing concern that overlapping patents in the field of genetics will create a costly and legally complex situation known as a patent thicket, which, along with the associated issues of accumulating royalty payments, can act as a disincentive for innovation. One potential means of...

Persistent link: https://www.econbiz.de/10013009585

Patent Pools and Clearinghouses in the Life Sciences : Back to the Future

Van Overwalle, Geertrui - 2016

Patents in the life sciences sector have sparked considerable debate over the past years. The grant of a series of patents for the screening of breast cancer (BRCA) genes led to wide controversy in Europe, the US and Australia. The grant of patents for plants resulting from essentially...

Persistent link: https://www.econbiz.de/10014129562

Analysing DNA Patents in Relation with Diagnostic Genetic Testing

Van Overwalle, Geertrui - 2015

In the ongoing debate concerning DNA patents, there is a need for empirical data. We aim at treating this data set for DNA patents related to diagnostic genetic testing. To this end we developed two tools to facilitate this process. First, we set up a search strategy to find the relevant...

Persistent link: https://www.econbiz.de/10014130792

Legal Uncertainty in the Area of Genetic Diagnostic Testing

Huys, Isabelle; Berthels, Nele; Matthijs, Gert; Van … - 2016

Ever since genes were first patented, the legitimacy and economics of human gene patents have been at the forefront of intense debate. Different stakeholders have expressed concerns about the effect of ‘blocking patents’ or ‘patent thickets’ on genetic technology, arguing that because...

Persistent link: https://www.econbiz.de/10014130795

Gene Patents and Collaborative Licensing Models : Patent Pools, Clearinghouses, Open Source Models and Liability Regimes

Van Overwalle, Geertrui - 2015

Concerns have been expressed that gene patents might result in restricted access to research and health care. The exponential growth of patents claiming human DNA sequences might result in patent thickets, royalty stacking and, ultimately, a ‘tragedy of the anti-commons’ in genetics. The...

Persistent link: https://www.econbiz.de/10014188461

Uncorking Trade Secrets : Sparking the Interaction Between Trade Secrecy and Open Biotechnology

Van Overwalle, Geertrui - 2014

The exchange of patented inventions and related know-how often takes place through bilateral or cross licenses. Our previous research examined the role of collaborative licensing models in streamlining access and use of patents, specifically in the field in genetics. The present essay examines...

Persistent link: https://www.econbiz.de/10014188465